Brian Plato is a Neurology physician affiliated with Norton Healthcare. OpenAlex indexes 14 publications with 230 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
81.1%Calcitonin gene-related peptide (CGRP) antagonists14.5%Aimovig Autoinjector51%Emgality Pen30%Ajovy Autoinjector13%Ajovy Syringe7%Part D<11 patientsSerotonin-1b and Serotonin-1d Receptor Agonist14.1%Sumatriptan Succinate51%Rizatriptan31%Naratriptan Hcl16%Eletriptan Hbr2%Part D<11 patients+ 14 more classes in this area
Musculoskeletal
7.9%gamma-Aminobutyric Acid-ergic Agonist2.9%Baclofen100%Part D≥31 patientsCentral alpha-2 Adrenergic Agonist2.7%Tizanidine Hcl100%Part D≥21 patients+ 3 more classes in this area
Respiratory
4.1%Phenothiazine2.3%Promethazine Hcl100%Part D≥17 patientsOther antihistamines for systemic use0.7%Cyproheptadine Hcl100%Part D≥11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A-82 Neurocognitive Improvement after Intra-Arterial Bevacizumab for Steroid-Refractory Radiation Necrosis of the Brain
Archives of Clinical Neuropsychology
2021 - Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial
Multiple Sclerosis and Related Disorders
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Don Stevens, MD
Norton Healthcare
Hassan Khan
Norton Healthcare
Terence Hadley, MD
Norton Healthcare
Mary Gordinier, MD
Norton Healthcare
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”